DARINA LINNIK: Open Payments
NPI 1043795909 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 16 payments from 10 companies in 2025. Trend: 2023 $575 · 2024 $75 · 2025 $400
Food & beverage: $365Education: $35
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 5 | $164 |
| Olympus America Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| IMMUNITYBIO, INC. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $19 |
| 180 Medical, Inc. | 1 | $18 |
| TOLMAR, INC. | 1 | $15 |
| Boston Scientific Corporation | 1 | $12 |
Products named: iTIND System, JELMYTO, IMFINZI, ANKTIVA, XTANDI, ERLEADA, AVEED, ELIGARD.
Industry payments across NM — which companies pay providers there.
